The emerging pathogen Candida auris has been associated with nosocomial outbreaks on
five continents. Genetic analysis indicates the simultaneous emergence of separate clades …

Invasive Candida infections remain an important cause of morbidity and mortality, especially
in hospitalized and immunocompromised or critically ill patients. A limited number of …

Background. Candida auris, a multidrug-resistant yeast that causes invasive infections, was
first described in 2009 in Japan and has since been reported from several countries …

The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

Candida auris has emerged globally as a multidrug-resistant yeast that can spread via
nosocomial transmission. An initial phylogenetic study of isolates from Japan, India …

Candidiasis, which includes both superficial infections and invasive disease, is the most
common cause of fungal infection worldwide. Candida bloodstream infections (BSI) cause …

Candida auris, a recently recognized, often multidrug-resistant yeast, has become a
significant fungal pathogen due to its ability to cause invasive infections and outbreaks in …

Background Candida auris has emerged globally as an MDR nosocomial pathogen in ICU
patients. Objectives We studied the antifungal susceptibility of C. auris isolates (n= 350) from …

Candida auris is an emerging multidrug-resistant yeast that causes serious invasive
infections with high mortality. It was first discovered in 2009, and since then, individual cases …

Background Candida auris is a globally emerging multidrug resistant fungal pathogen
causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London …